Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6353163B2 - - Google Patents
[go: Go Back, main page]

JPS6353163B2 - - Google Patents

Info

Publication number
JPS6353163B2
JPS6353163B2 JP55028004A JP2800480A JPS6353163B2 JP S6353163 B2 JPS6353163 B2 JP S6353163B2 JP 55028004 A JP55028004 A JP 55028004A JP 2800480 A JP2800480 A JP 2800480A JP S6353163 B2 JPS6353163 B2 JP S6353163B2
Authority
JP
Japan
Prior art keywords
iodine
eggs
composition
egg
feed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55028004A
Other languages
Japanese (ja)
Other versions
JPS56125314A (en
Inventor
Shinichiro Katamine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Nosan Kogyo Co Ltd
Original Assignee
Nihon Nosan Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nosan Kogyo Co Ltd filed Critical Nihon Nosan Kogyo Co Ltd
Priority to JP2800480A priority Critical patent/JPS56125314A/en
Priority to GR63529A priority patent/GR82331B/el
Priority to DE3048700A priority patent/DE3048700C2/en
Priority to CA000367730A priority patent/CA1158983A/en
Priority to PT72570A priority patent/PT72570B/en
Priority to AT81300937T priority patent/ATE8195T1/en
Priority to EP81300937A priority patent/EP0035882B1/en
Priority to DE8181300937T priority patent/DE3164511D1/en
Publication of JPS56125314A publication Critical patent/JPS56125314A/en
Publication of JPS6353163B2 publication Critical patent/JPS6353163B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は血中の高比重リポ蛋白構成比を改善さ
せる組成物、更に詳細にいえば、ヨウ素を含有す
る特殊の卵を有効成分とする組成物に関するもの
である。 過去10数年、アメリカにおいては鶏卵の消費量
が低落の一途を辿つており、近年わが国において
も同様にその消費量は横這ないしは低下の傾向に
ある。これらの原因は食物中のコレステロール
が血清コレステロールを増加させる、人体の血
清コレステロールの増加は心臓の冠状動脈疾患の
危険を増す、という2段階の仮説が現われ、これ
が鶏卵の食べすぎは心臓の危険を招くという見解
に発展したことによるものと思われる。一方、そ
の反論として、通常の食事に加え、卵を1日1個
から3個を人に数ケ月にわたり投与しても、血清
コレステロールの平均水準には有意の差がみられ
ないという試験報告が多くあること、卵の栄養価
値は明白であり、心臓病を予防する手段として、
鶏卵の摂取制限が妥当であることの証明がないこ
となどを挙げているが、卵の消費低下傾向に歯止
めをかけるに到つていない。しかしながら、最近
では多くの研究者の研究により、血清コレステロ
ールの問題は総含有量の問題でなく、どのような
タイプのものがどれ位含まれているかどうかを問
題とするべきであるとされている。即ち、高比重
リポ蛋白の量が高水準である場合は冠状動脈硬化
に対して保護し、低比重リポ蛋白の含有量が高い
場合は、心臓病を発生、進展させる兆候である、
との考え方が大勢を占めるようになり、これらに
影響を与えるものとして運動、アルコール、各種
薬物の影響が論議されている。そして高比重リポ
蛋白の量が低下するときは、同時に低比重リポ蛋
白の増加が認められることが多いのであるが、動
脈硬化進展の抑制には、低比重リポ蛋白を低減さ
せるとともに高比重リポ蛋白値を増加させるこ
と、すなわち血中の高比重リポ蛋白構成比の改善
が望まれるのである。高比重リポ蛋白の血中濃度
における割合を増加させる方策は、食事療法にお
いても種々検討され、卵黄も研究テーマの1つと
して取り挙げられているが、卵黄を人に負荷した
場合、低比重リポ蛋白は著しく上昇するのに対
し、高比重リポ蛋白の増加は軽度であると報告さ
れている(日大医誌38,1295,′76)。また高脂血
症における食事療法としてはエネルギーの適正
化、糖質の適正なる制限、多価不飽和脂肪酸と飽
和脂肪酸のバランスをよくすることなどが、高比
重リポ蛋白を増加させるものであると知られてい
る。しかし、バランスを崩して多価不飽和脂肪酸
を多くすると低比重リポ蛋白、高比重リポ蛋白を
ともに低下させてしまうこと、および食事療法は
長期にわたり本人の強い意志がなければできない
ことなど、実行においては難点があるので、日常
生活において食品と同様に簡単にかつ無理なく摂
取でき、上記構成比を確実に改善できるものの開
発が望まれている。 このような状況下、本発明者は飼料に添加した
微量成分の卵成分に及ぼす影響並びに卵成分の脂
質代謝及び血中コレステロール等に及ぼす影響等
について研究中、ヨウ素を高含有させてなる卵に
血中の高比重リポ蛋白構成比を改善させる作用の
あることを見い出し本発明を完成した。 即ち、本発明の組成物の要旨は、卵中にヨウ素
を卵1個当たり550μg以上移行させ、1日当たり
ヨウ素量として550〜200μg摂取可能にして血中
の高比重蛋白構成比を改善させることである。本
発明者の調査においては、ヨウ素ならびにヨウ素
を高含有する食品あるいは組成物に血中の高比重
リポ蛋白構成比を改善させる作用があるとの報告
は全くなく、本発明は先駆的な発明であるといえ
る。 本発明に係る組成物の有効成分となるヨウ素を
550μg以上含有する卵は通常次のようにして得
る。 すなわち、ヨウ素酸カルシウム、ヨウ素酸カリ
ウム、ヨウ素酸ナトリウム、ヨードカリ、ヨウ化
ナトリウム、ヨウ化銅、ヨウ化チモール、カルシ
ウムヨードビヘメイト、ジヨードサリチル酸、過
ヨウ素酸カルシウムなどのヨウ素化合物、あるい
はコンブなどヨウ素を多く含有する海藻類、ある
いはその処理物などを一定量以上飼料に混合し、
これを鳥類に投与して卵中のヨウ素含量を増加さ
せるのである。この際ヨウ素化合物としてはヨウ
素酸カルシウムを使用することが鳥の健康、ヨウ
素の卵への移行率等より好ましく、またコンブな
どの海藻類を併用するとさらに好ましい。また鳥
類に投与するヨウ素量としては、鳥類の種類、例
えば鶏、鶉などにより異なるが、産卵鶏の場合は
1日につき1羽約10〜250mg、卵そのものを主体
とする場合は10〜15mg程度投与するのが好まし
い。 通常は飼料に混合して投与するが、その場合1
日1羽約100g飼料を摂取するとして、飼料中100
〜2500ppm、卵そのままの形で本発明の組成物と
する場合は100〜150ppmのヨウ素が配合されるよ
うにすればよい。 このようにして、ヨウ素化合物あるいはヨウ素
を多く含有する物質を鳥類に投与すると、約1週
間後には、目的とするヨウ素を多く含有する卵が
産出される。例えば産卵鶏の場合、飼料中
100ppm程度のヨウ素を含有する飼料を投与した
場合、卵1個あたり約600〜800μg程度のヨウ素
を含有する卵が産出されるものである。通常、産
卵鶏におけるヨウ素の要求量は飼料Kgあたり0.30
〜0.35mg(NRC)であり、実際の市販飼料中の
ヨウ素量も0.3〜2.0mg/Kgになつているが、この
市販飼料で飼育された鶏より産出された普通の卵
のヨウ素量は1個あたり約6μg程度(American
Egg Board)、多くとも1個あたり30μg程度のも
のとなる。この普通の卵に比し、上記のようにし
て得た卵は格段とヨウ素を高含有している。 このようにしてヨウ素を卵1個当たり550μg以
上移行せしめて得た卵はそのままの形で、本発明
組成物として用いることができるし、また乾燥、
濃縮、粉末化、顆粒化などの処理を施してもよ
く、さらに各種の賦形剤、又は結合剤などを混合
して、錠剤、粉剤等の形にして使用することもで
きる。 これら卵をそのままの形で組成物として用い
ず、卵処理品を組成物とする場合は、鳥類に投与
するヨウ素の含量を高めて卵中のヨウ素を高く
し、少量の摂取で1日当たり550〜2000μgを摂取
可能にするのが望ましい。 本組成物に関する毒性試験結果については大略
次の通りである。 急性毒性試験 使用動物 ラツト Wister系 雌 体 重 100〜110g (n=10) ヨウ素含有量の高い卵粉を使用し、等比級数的
投与量により、ラツト体重1Kg当り、ヨウ素量と
して50mgまで経口投与して7日後に観察した。そ
の結果斃死するものは1頭もおらず、また体重減
も認められなかつた。本組成物には上記の如く全
く急性毒性が認められなかつた。 また本組成物の血中の高比重リポ蛋白構成比を
改善させる作用に関する動物試験を行つた結果
は、次の通りである。 実験例 1 3週令のSD系雄ラツト28頭を自発運動装置付
ケージ内において、最初の10日間、市販の固型基
礎飼料で予備飼育した後、粉末基礎飼料(日本農
産工業〓製)に切り換え、摂食が8〜9時、21〜
22時の2回のミールフイーデイングにより飼育し
た。7周令時に体重と自発運動量が平均化するよ
うに14頭ずつに分け、試験区と対照区の2群と
し、第1区は試験区として、粉末基礎飼料に後記
実施例2で得たヨウ素を高含有する卵粉を2%加
えて調製したもの(試験飼料)を給餌し、第2区
は対照区として、粉末基礎飼料に普通の卵粉を2
%加えて調製したもの(対照飼料)を給餌し、更
に10週間飼育した。 実施例2で得たヨウ素を高含有する卵粉並びに
普通卵粉の成分組成は第1表の通りであり、また
それぞれの卵粉を加えて調製した試験飼料と対照
飼料の成分組成は第2表に通りである。
The present invention relates to a composition that improves the composition ratio of high-density lipoproteins in blood, and more specifically, to a composition containing a special egg containing iodine as an active ingredient. Over the past ten years, the consumption of eggs in the United States has been on a steady decline, and in recent years in Japan, the consumption has also been flat or on the decline. A two-step hypothesis has emerged that explains these causes: dietary cholesterol increases serum cholesterol, and an increase in serum cholesterol in the human body increases the risk of coronary heart disease. This seems to be due to the development of the idea of inviting people. On the other hand, as a counter-argument, there is a study report that shows that there is no significant difference in the average level of serum cholesterol when people are given one to three eggs a day for several months in addition to their normal diet. The nutritional value of eggs is clear, and as a means of preventing heart disease.
The government cites the lack of proof that restricting the intake of chicken eggs is appropriate, but the trend of declining egg consumption has not been stopped. However, recent studies by many researchers have shown that the issue of serum cholesterol should not be a question of the total content, but rather what type and how much of it is included. . That is, a high level of high-density lipoprotein protects against coronary atherosclerosis, and a high level of low-density lipoprotein is a sign of the development and progression of heart disease.
The majority of people now believe that this is the case, and the effects of exercise, alcohol, and various drugs are being discussed as influences on this. When the amount of high-density lipoprotein decreases, an increase in low-density lipoprotein is often observed at the same time, but in order to suppress the progression of arteriosclerosis, it is necessary to reduce low-density lipoprotein as well as high-density lipoprotein. It is desired to increase the value, that is, to improve the composition ratio of high-density lipoproteins in the blood. Various measures to increase the blood concentration of high-density lipoproteins have been studied in dietary therapy, and egg yolk has also been taken up as one of the research topics. It has been reported that while protein increases markedly, the increase in high-density lipoprotein is mild (Nihon University Medical Journal 38, 1295, '76). In addition, dietary therapy for hyperlipidemia includes optimizing energy, restricting carbohydrates appropriately, and improving the balance between polyunsaturated fatty acids and saturated fatty acids, which increase high-density lipoproteins. Are known. However, if the balance is disrupted and the amount of polyunsaturated fatty acids is increased, both low-density lipoprotein and high-density lipoprotein will decrease, and diet therapy cannot be carried out over a long period without strong will from the individual. However, there is a need for the development of something that can be easily and reasonably ingested in daily life in the same way as food, and that can reliably improve the above composition ratio. Under these circumstances, the present inventor is currently researching the effects of trace ingredients added to feed on egg components, as well as the effects of egg components on lipid metabolism and blood cholesterol. The present invention was completed by discovering that the present invention has the effect of improving the composition ratio of high-density lipoproteins in the blood. That is, the gist of the composition of the present invention is to transfer 550 μg or more of iodine per egg into eggs, to enable intake of 550 to 200 μg of iodine per day, and to improve the composition ratio of high-density proteins in the blood. be. In the investigation conducted by the present inventor, there have been no reports that iodine or foods or compositions containing high iodine have the effect of improving the composition ratio of high-density lipoproteins in the blood, and the present invention is a pioneering invention. It can be said that there is. Iodine, which is an active ingredient of the composition according to the present invention,
Eggs containing 550 μg or more are usually obtained as follows. Namely, iodine compounds such as calcium iodate, potassium iodate, sodium iodate, potash iodide, sodium iodide, copper iodide, thymol iodide, calcium iodobehemate, diiodosalicylic acid, calcium periodate, or kelp. By mixing more than a certain amount of iodine-rich seaweed or its processed products into the feed,
This is administered to birds to increase the iodine content in their eggs. In this case, it is preferable to use calcium iodate as the iodine compound in terms of the health of the birds and the transfer rate of iodine to eggs, and it is even more preferable to use seaweed such as kelp in combination. The amount of iodine administered to birds varies depending on the type of bird, e.g. chickens, quails, etc., but in the case of egg-laying hens, it is approximately 10 to 250 mg per bird per day, and in the case of feeding mainly on eggs, it is approximately 10 to 15 mg. Preferably, it is administered. It is usually administered by mixing with feed, but in that case 1
Assuming that one bird ingests approximately 100g of feed per day, 100 g of feed is consumed per day.
~2,500 ppm of iodine may be blended, and when the composition of the present invention is made from eggs as they are, 100 to 150 ppm of iodine may be blended. When an iodine compound or a substance containing a large amount of iodine is administered to birds in this manner, the desired eggs containing a large amount of iodine are produced approximately one week later. For example, in the case of laying hens,
When feed containing about 100 ppm of iodine is administered, eggs containing about 600 to 800 μg of iodine per egg are produced. Normally, the iodine requirement for laying hens is 0.30 per kg of feed.
~0.35 mg (NRC), and the actual amount of iodine in commercial feed is 0.3 to 2.0 mg/Kg, but the amount of iodine in ordinary eggs produced by chickens raised on this commercial feed is 1. Approximately 6μg per piece (American
(Egg Board), each one contains about 30μg at most. Compared to ordinary eggs, the eggs obtained as described above have a much higher content of iodine. Eggs obtained by transferring 550 μg or more of iodine per egg in this way can be used as they are as the composition of the present invention, or they can be dried,
It may be subjected to treatments such as concentration, powdering, and granulation, and may also be used in the form of tablets, powders, etc. by mixing with various excipients or binders. If these eggs are not used in their raw form as a composition and a processed egg product is used as a composition, the content of iodine administered to birds can be increased to increase the iodine content in the eggs. It is desirable to be able to ingest 2000 μg. The toxicity test results for this composition are roughly as follows. Acute toxicity test Animals used Wister female rats Body weight 100-110 g (n=10) Using egg powder with high iodine content, orally administer up to 50 mg of iodine per 1 kg of rat body weight using a geometric series of doses. and observed 7 days later. As a result, not a single animal died, and no weight loss was observed. As mentioned above, no acute toxicity was observed in this composition. Furthermore, the results of an animal test regarding the effect of this composition on improving the composition ratio of high-density lipoproteins in blood are as follows. Experimental Example 1 Twenty-eight 3-week-old SD male rats were preliminarily fed with a commercially available solid basal diet for the first 10 days in a cage with a locomotor device, and then fed with a powdered basal diet (manufactured by Nihon Nosan Kogyo Co., Ltd.). Change, feeding time is 8-9am, 9pm-
The animals were fed with two meals at 10pm. At 7 weeks of age, the animals were divided into 14 groups so that their body weight and locomotor activity were averaged, and the animals were divided into two groups: a test group and a control group. The test feed was prepared by adding 2% of egg powder with a high content of
% (control feed) was added to the feed, and the animals were kept for an additional 10 weeks. The component compositions of the iodine-rich egg powder and regular egg powder obtained in Example 2 are shown in Table 1, and the component compositions of the test feed and control feed prepared by adding each egg powder are shown in Table 2. It is as shown in the table.

【表】【table】

【表】 飼育室の温度を25±2℃、湿度を50〜80%に保
つて飼育した。試験並びに対照飼料をそれぞれの
区のラツトに10週間投与した後、摂取前後の17
時、21時、24時の3時点で断頭により屠殺し、血
中の総コレステロール、高比重リポ蛋白コレステ
ロール量を測定し、かつ血中の高比重リポ蛋白構
成比(HDL比)を算出した。なお各屠殺時点の
間に差は認められなかつたので、成績結果は第3
表の通り一緒にまとめた。結果より明らかなよう
に血中の高比重リポ蛋白構成比が改善された。
[Table] The animals were kept in a breeding room at a temperature of 25±2°C and a humidity of 50 to 80%. After administering the test and control diets to rats in each group for 10 weeks,
The rats were sacrificed by decapitation at 3:00 p.m., 9:00 p.m., and 24:00, and the total cholesterol and high-density lipoprotein cholesterol levels in the blood were measured, and the composition ratio of high-density lipoproteins in the blood (HDL ratio) was calculated. Since no differences were observed between each slaughter time, the performance results are based on the third
They are summarized as shown in the table. As is clear from the results, the composition ratio of high-density lipoproteins in the blood was improved.

【表】【table】

【表】 実験例 2 3週令のSD系雄ラツト26頭を、自発運動装置
がついていないケージで飼育し、自発運動装置に
よる運動をさせることなく、週1回、水温30℃流
速約40m/minに設定した強制遊泳運動装置でラ
ツトが疲労困ぱいするまで運動を負荷させた以外
は、実験例1と全く同様な飼育試験を行い、第1
区試験区14頭、第2区対照区12頭の血中の総コレ
ステロールおよび高比重リポ蛋白コレステロール
量を実施例1と同様な方法で測定した。結果は第
4表の通りであり、血中の高比重リポ蛋白構成比
を改善させることが明らかである。
[Table] Experimental Example 2 Twenty-six 3-week-old SD male rats were kept in a cage without a locomotor device, and once a week, water temperature was 30°C and flow rate was approximately 40 m/min without exercise using the locomotor device. A rearing test was carried out in exactly the same manner as in Experiment 1, except that the rats were subjected to exercise until they were exhausted using a forced swimming exercise device set at min.
Total cholesterol and high-density lipoprotein cholesterol levels in the blood of 14 animals in the experimental group and 12 animals in the second control group were measured in the same manner as in Example 1. The results are shown in Table 4, and it is clear that the composition ratio of high-density lipoproteins in the blood is improved.

【表】 また、本組成物の血中の高比重リポ蛋白構成比
を改善させる作用に関する臨床結果は、次の通り
である。 臨床例 高コレステロール血症の通院患者10人に、後記
実施例2で得たヨウ素を高含有する卵粉を約2〜
3ケ月間1日3g投与し、投与前、投与後の血中
の総コレステロール、高比重リポ蛋白コレステロ
ール、低比重リポ蛋白量を測定した。その結果は
第5表の通りであり、高比重リポ蛋白コレステロ
ールが増え、低比重リポ蛋白が低減していること
が明らかである。
[Table] Furthermore, the clinical results regarding the effect of this composition on improving the composition ratio of high-density lipoproteins in blood are as follows. Clinical example: Ten patients with hypercholesterolemia were given egg powder containing high iodine, obtained in Example 2 below, for about 2 to 30 minutes.
3 g per day was administered for 3 months, and the total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein amount in the blood were measured before and after administration. The results are shown in Table 5, and it is clear that high-density lipoprotein cholesterol increased and low-density lipoprotein decreased.

【表】 上記実験例並びに臨床例から、本発明の組成物
に、血中の高比重リポ蛋白構成比を改善する作用
があることは明らかである。 本発明における血中の高比重リポ蛋白構成比を
改善させる作用機構は明らかではないが、鶏の体
内を通り、卵に移行したヨウ素が卵の成分と結合
し、リポ蛋白あるいはリポ蛋白リパーゼに直接な
いしは間接に作用して、リポ蛋白の比重による構
成比を改善しているものと推察される。 本発明の組成物は栄養的にも極めて優れてお
り、副作用もなく、その効果も速効性でなく遅効
性であるので継続的に摂取することが望ましい。
本発明者の知見によれば、卵1個あたりのヨウ素
量を550〜1000μg程度となるようにし、1日につ
き卵を1〜2個食する程度とすれば、1日当たり
ヨウ素量として550〜2000μgを日常生活中極めて
容易に摂取可能となり、また粉末化あるいは顆粒
化等卵を処理して組成物とした場合は、高含有す
る組成物を少量摂取して1日当たりヨウ素量とし
て550〜2000μg摂取するようにすればよい。約1
ケ月後程度の後にはその改善効果が現われてくる
ものである。そして長期にわたり摂取しても血中
の高比重リポ蛋白の構成比を異常なものとするこ
とはないので、心臓病等を心配することなく本発
明の組成物を食することができる。 実施例 1 市販の成鶏用飼料にヨウ素酸カルシウムをヨウ
素含量として100ppmになるよう添加し、この飼
料を産卵し始めてから3ケ月後の鶏に給与し飼育
した。その10日過ぎより、平均550μg/個のヨウ
素を含有する卵を得た。 実施例 2 市販の成鶏用飼料にヨウ素酸カルシウムをヨウ
素量として2000ppmになるように添加し、さらに
海藻粉末を1%添加し、この飼料を産卵し始めて
から7ケ月後の鶏100羽に給与し飼育した。上記
飼育により得られた卵の1個当たりのヨウ素含有
量は5300μgであつた。この卵のうち170Kgをスプ
レードライヤーにて乾燥し、35Kgの本発明の組成
物を得た。本卵粉組成物のヨウ素含量は411mg/
Kgであつた。 実施例 3 市販の成鶏用飼料に過ヨウ素酸カルシウムをヨ
ウ素量を150ppmとなるよう添加し、実施例1と
同様な方法で平均1250μg/個のヨウ素を含有す
る卵を得た。そして、これらの卵を割卵後10%の
デキストリンを加え、さらに水を加えてよく混合
し、スプレードライヤーにて噴霧乾燥し、本発明
の組成物を得た。 実施例 4 市販の成鶏用飼料にジヨードサリチル酸をヨウ
素が100ppmとなるよう添加し、さらにコンブ粉
末を1%加え、この飼料を実施例1と同様に産卵
鶏に与え、平均700μg/個のヨウ素を含有する卵
を得た。
[Table] From the above experimental examples and clinical examples, it is clear that the composition of the present invention has the effect of improving the composition ratio of high-density lipoproteins in blood. Although the mechanism of action of the present invention to improve the composition ratio of high-density lipoproteins in the blood is not clear, iodine that passes through the chicken's body and transfers to eggs combines with egg components and is directly transferred to lipoproteins or lipoprotein lipase. It is presumed that it acts indirectly or improves the composition ratio based on the specific gravity of lipoproteins. The composition of the present invention is nutritionally excellent, has no side effects, and has slow-acting rather than quick-acting effects, so it is desirable to take it continuously.
According to the findings of the present inventor, if the amount of iodine per egg is about 550 to 1000 μg and if you eat 1 to 2 eggs per day, the amount of iodine per day is 550 to 2000 μg. It is extremely easy to ingest iodine in daily life, and if eggs are processed into a composition such as powdered or granulated, a small amount of the composition with high iodine content is ingested and the amount of iodine is 550 to 2000 μg per day. Just do it like this. Approximately 1
The improvement effect will appear after about a few months. Furthermore, even if ingested over a long period of time, the composition of high-density lipoproteins in the blood will not become abnormal, so the composition of the present invention can be consumed without worrying about heart disease or the like. Example 1 Calcium iodate was added to a commercially available feed for adult chickens to give an iodine content of 100 ppm, and this feed was fed to chickens 3 months after they started laying eggs and raised. After 10 days, eggs containing an average of 550 μg of iodine were obtained. Example 2 Calcium iodate was added to commercially available adult chicken feed to give an iodine content of 2000 ppm, and 1% seaweed powder was added, and this feed was fed to 100 chickens 7 months after they started laying eggs. I bred them. The iodine content per egg obtained by the above breeding was 5300 μg. 170 kg of these eggs were dried using a spray dryer to obtain 35 kg of the composition of the present invention. The iodine content of this egg powder composition is 411mg/
It was Kg. Example 3 Calcium periodate was added to a commercially available feed for adult chickens so that the amount of iodine was 150 ppm, and eggs containing an average of 1250 μg/piece of iodine were obtained in the same manner as in Example 1. After breaking these eggs, 10% dextrin was added, water was added, and the mixture was thoroughly mixed and spray-dried using a spray dryer to obtain the composition of the present invention. Example 4 Diiodosalicylic acid was added to a commercially available feed for adult chickens so that the iodine content was 100 ppm, and 1% of kelp powder was added, and this feed was given to laying hens in the same manner as in Example 1. Eggs containing iodine were obtained.

Claims (1)

【特許請求の範囲】[Claims] 1 鳥類にヨウ素化合物および/または海藻類を
一定量以上投与して、卵中にヨウ素を卵1個当た
り550μg以上移行させ、1日当たりヨウ素量とし
て550〜2000μg摂取可能にした卵または卵処理品
を主体とすることを特徴とする、血中の高比重蛋
白構成比を改善させる組成物。
1. Eggs or egg-processed products that are made by administering a certain amount or more of iodine compounds and/or seaweed to birds so that 550 μg or more of iodine is transferred to each egg, allowing them to ingest 550 to 2000 μg of iodine per day. 1. A composition for improving the composition ratio of high-density proteins in the blood, characterized in that the composition contains the following:
JP2800480A 1980-01-18 1980-03-07 Composition for improving constitutional ratio of lipoprotein with high specific gravity in blood Granted JPS56125314A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2800480A JPS56125314A (en) 1980-03-07 1980-03-07 Composition for improving constitutional ratio of lipoprotein with high specific gravity in blood
GR63529A GR82331B (en) 1980-01-18 1980-12-02
DE3048700A DE3048700C2 (en) 1980-01-18 1980-12-23 Pharmaceutical preparation for improving lipid metabolism
CA000367730A CA1158983A (en) 1980-01-18 1980-12-30 Bird feed mixture to produce iodine enriched eggs
PT72570A PT72570B (en) 1980-03-07 1981-02-25 A method for producing a composite for improving lipid metabo lism
AT81300937T ATE8195T1 (en) 1980-03-07 1981-03-06 PROCESS FOR PRODUCING IODINE-FORTIFIED EGGS.
EP81300937A EP0035882B1 (en) 1980-03-07 1981-03-06 Method for producing iodine-enriched eggs
DE8181300937T DE3164511D1 (en) 1980-03-07 1981-03-06 Method for producing iodine-enriched eggs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2800480A JPS56125314A (en) 1980-03-07 1980-03-07 Composition for improving constitutional ratio of lipoprotein with high specific gravity in blood

Publications (2)

Publication Number Publication Date
JPS56125314A JPS56125314A (en) 1981-10-01
JPS6353163B2 true JPS6353163B2 (en) 1988-10-21

Family

ID=12236639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2800480A Granted JPS56125314A (en) 1980-01-18 1980-03-07 Composition for improving constitutional ratio of lipoprotein with high specific gravity in blood

Country Status (2)

Country Link
JP (1) JPS56125314A (en)
PT (1) PT72570B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6470230B2 (en) * 2016-05-31 2019-02-13 オカヤス株式会社 Oryzanol egg

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50145511A (en) * 1974-05-14 1975-11-21

Also Published As

Publication number Publication date
JPS56125314A (en) 1981-10-01
PT72570B (en) 1982-07-26
PT72570A (en) 1981-03-01

Similar Documents

Publication Publication Date Title
CA1268123A (en) Dietary products and uses comprising methylsulfonylmethane
JP3390846B2 (en) Use of biomass
DE69304118T2 (en) Composition of material containing omega-3 fatty acids and a glutathione stimulator for the treatment of immune diseases and viral infections
EP0941088B1 (en) Use of conjugated linoleic acid to enhance natural killer lymphocyte function
US6245364B1 (en) Weight reduction method for cats and other pets
Emara Comparative Effects of Nano-Selenium and Sodium Selenite Supplementation on Blood Biochemical Changes in Relation to Growth Performance of Growing New Zealand White Rabbits.
JPS6313967B2 (en)
DE60220899T2 (en) MEDIUM AGAINST STRESS-INDIRECTED DISEASES
EP0035882B1 (en) Method for producing iodine-enriched eggs
Fisher et al. Further studies on the alfalfa factor and its relation to the liver and whey factors
Abd-Allah et al. Influence of using flavomycin and propolis as feed additives on buffalo milk production, and growth performance and blood metabolites of suckling calves
JPS5832867B2 (en) Eggs containing high concentrations of lysozyme and iodine
US4394376A (en) Method for preventing hypertriglyceridemia
JP2004000171A (en) Functional food product containing maca
JPS6353163B2 (en)
AU2008259372B2 (en) Means and methods for enhancing weight gain in poultry
Nelson et al. Factors affecting the vitamin K requirement of the chick
Tinsley DDT Effect on Rats Raised on Alpha-protein Rations: Growth and storage of liver vitamin A
JPS59232069A (en) Egg having antiaging activity
JPS6332331B2 (en)
Al-Janabi et al. Effect of vitamin C administration on serum and egg-yolk cholesterol level of the chicken
Alexander et al. The influence of lipotropic factors on the prevention of nutritional edema in the rat
RU2323733C2 (en) Method of prevention of lesions caused by iodin radionuclides and optimisation of iodin metabolism in post-preventive period
JP3212364B2 (en) New royal jelly formulation
JPS61151129A (en) Absorbefacient for vitamin e